Analyst consensus rating
Boston Scientific Analyst Rating: Buy
Direct answer
Boston Scientific's consensus rating is Buy.
28 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $50.67.
Forecast evidence checked November 2, 2026.
Get free Boston Scientific email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $41.98
- Average price target
- $50.67
- High price target
- $78.00
- Low price target
- $41.00
- Low target gap
- -2.3%
- Target upside
- +20.7%
- High target gap
- +85.8%
- Target range width
- 88.1%
- Consensus rating
- Buy
- Analysts
- 28
- Evidence date
- November 2, 2026
- Valid through
- November 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Boston Scientific?
Boston Scientific has a verified Buy consensus. The same dataset has an average price target of $50.67.
How far are Boston Scientific's low and high targets from the recorded price?
The low target implies -2.3%, while the high target implies +85.8%.
How many analysts are included in Boston Scientific's consensus?
The verified consensus includes 28 analysts.
How is Boston Scientific's target upside or downside calculated?
The average target of $50.67 is divided by the recorded price of $41.98, then one is subtracted to produce +20.7%. This does not guarantee a future return.
When was Boston Scientific's analyst forecast verified?
The data was verified on 2026-11-02. The dataset is valid through 2026-11-09.